SUMMARY: Researchers will study the effects of exposure to environmental pollutants on the hemangiosarcoma risk in dogs enrolled in the Golden Retriever Lifetime Study.
October 24, 2022 — The Cathie Turner Sunbeam Fund for Hemangiosarcoma Research opens discovery opportunities for new diagnostics and treatments for this deadly cancer in dogs.
July 29, 2025 – Morris Animal Foundation announced the funding of four new research projects aimed at hemangiosarcoma in dogs, an aggressive and almost uniformly fatal canine cancer.
January 27, 2023 – The Foundation announced a new multiyear, multimillion-dollar research initiative focused on hemangiosarcoma, the leading cause of cancer deaths in the Golden Retriever Lifetime Study.
June 6, 2019 – Chase Manhattan (the cream colored dachshund, not the bank) beat the odds and survived hemangiosarcoma. Read about her amazing story of survival.
April 5, 2018 – Carol Everett tells the story of her dog Davy, a therapy dog who's mission was to bring love to those in need, and his struggle with hemangiosarcoma.
PRESS RELEASE: February 28, 2024 — Thanks to long-time supporter Nan Stuart, Morris Animal Foundation will be able to fund more studies aimed at prevention, detection and treatment of canine hemangiosarcoma.
October 15, 2022 – The Foundation announces a new research initiative on hemangiosarcoma, the leading cause of cancer deaths in the Golden Retriever Lifetime Study.